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One in nine people worldwide is 60 years or older, and this
proportion is projected to increase to one in five by 2050.1 With
a prevalence of dementia between 6 and 7% of over 65-year-olds,2
cognitive decline in ageing populations is creating an increasing
social and financial challenge, although traditional estimates
may overestimate the detrimental effects of age in the contemporary
population.2–4 Advanced imaging techniques, such as magnetic
resonance imaging (MRI), allow for detailed investigation of the
ageing brain. Visual inspection of structural MRIs is a quick and
reliable technique that does not require specialist software
pipelines or expertise, and is routinely used in clinical practice,
unlike automated analysis. Visual inspections can be used to
detect atrophy in the grey matter (particularly the medial temporal
lobe), and hyperintensities in white matter, which have been high-
lighted as correlates of functional impairment and dementia.5,6 In
people over 60 years, such minor MRI abnormalities are, however,
often characterised as ‘normal for age’. However, the functional
implications of these changes identified by visual inspection are
unclear; hence it is difficult for the clinician to ascribe significance
to them. Moreover, apart from a few exceptions,7 studies of
cognitive deficits have ignored factors that may confer functional
resilience against structural brain damage.
This paper describes the cognitive profile and routine MRI
findings from the first quarter of the Whitehall II imaging
substudy of 800 participants.8 This sample was recruited from
the Whitehall II occupational cohort of 6035 civil servants
from 20 UK Government departments in London.9 Among 208
participants aged 60–82, we examine the relationship between
MRI abnormalities, often described as age-related, and performance
on tests estimating premorbid intelligence and cognitive impair-
ment, in relation to factors that may confer resilience against
cognitive impairment, including education and premorbid IQ.
We define resilience as the positive effect of variables on cognitive
outcome given a certain severity of risk factors or organic changes
of the brain. Our hypotheses were that cognitive impairment
measured by the Montreal Cognitive Assessment (MoCA) would
be associated with brain abnormalities, in particular hippocampal
atrophy and deep white matter changes, after controlling for
confounders, such as age, gender, education and premorbid IQ.
At the same time, we predicted that with a given degree of brain
abnormality (hippocampal atrophy or deep white matter changes)
and other confounders being equal, higher premorbid IQ and
education would predict a higher MoCA score, i.e. a smaller
chance of cognitive impairment.
Method
Participants
The Whitehall II study was established in 1985 at University
College London, and recruited 10 308 non-industrial civil servants
across a range of employment grades. Eight hundred of these were
randomly selected for the current Whitehall II imaging sub-study,8
from a cohort of approximately 6035 community-dwelling elders
(29 were oversampled from participants previously scoring higher
(score 516) on the Centre for Epidemiologic Studies Depression
(CES-D) scale and are included in this study). This paper
describes results from the first 208 participants recruited to the
imaging substudy. Participants gave informed consent and
attended the investigation in Oxford, unless MRI was
contraindicated.
Magnetic resonance imaging
MRI scans were acquired at the University of Oxford Functional
Magnetic Resonance Imaging of the Brain (FMRIB) Centre, using
a 3 Tesla Siemens scanner (see online supplementary materials and
435
Resilience and MRI correlates of cognitive
impairment in community-dwelling elders
Anya Topiwala, Charlotte L. Allan, Vyara Valkanova, Eniko´´ Zsoldos, Nicola Filippini,
Claire E. Sexton, Abda Mahmood, Archana Singh-Manoux, Clare E. Mackay, Mika Kivima¨ki
and Klaus P. Ebmeier
Background
The contribution of education and intelligence to resilience
against age-related cognitive decline is not clear, particularly
in the presence of ‘normal for age’ minor brain abnormalities.
Method
Participants (n=208, mean age 69.2 years, s.d. = 5.4) in the
Whitehall II imaging substudy attended for neuropsychological
testing and multisequence 3T brain magnetic resonance
imaging. Images were independently rated by three trained
clinicians for global and hippocampal atrophy, periventricular
and deep white matter changes.
Results
Although none of the participants qualified for a clinical
diagnosis of dementia, a screen for cognitive impairment
(Montreal Cognitive Assessment (MoCA) 526) was abnormal
in 22%. Hippocampal atrophy, in contrast to other brain
measures, was associated with a reduced MoCA score
even after controlling for age, gender, socioeconomic status,
years of education and premorbid IQ. Premorbid IQ and
socioeconomic status were associated with resilience in the
presence of hippocampal atrophy.
Conclusions
Independent contributions from a priori risk (age,
hippocampal atrophy) and resilience (premorbid function,
socioeconomic status) combine to predict measured
cognitive impairment.
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protocol paper8 for further details). Images from the T1-weighted
and FLAIR (fluid-attenuated inversion recovery) sequences were
used for visual inspection.
MRI analysis
Scans were assessed independently by three medically qualified
researchers (A.T., C.L.A. and V.V.) trained in visual inspection
techniques, masked to behavioural details and participant identity
for: global atrophy, hippocampal atrophy and white matter
changes. Global atrophy was assessed viewing supra-ventricular
axial slices and rated from absent (0) to severe (3). Standards
for each grade had been agreed in advance in consultation with a
fourth researcher with expertise in this field (K.P.E.). Hippocampal
atrophy was assessed by the Scheltens scale separately for each
side according to the width of the choroid fissure, width of the
temporal horn and height of the hippocampus (0–4).5 White
matter changes were graded by the Fazekas scale depending on
the presence and size of deep white matter changes (0–3), and
the presence or extent of periventricular white matter changes
(0–3).10 This scale provides two different scores each, rated on a
4-point scale.
After recording scores separately, disagreements were settled in
consultation with a fourth researcher (K.P.E.) and a consensus
score reached. Raters remained masked to all other participant
data. Intra- (on a random 10% of 208 scans) and interrater
reliability (n= 208) were assessed by intraclass correlation
coefficients (ICCs). For the purpose of the statistical analysis,
global atrophy and Fazekas scores were rated as abnormal if
41; hippocampal atrophy was only recorded, if both Scheltens
scores were 41.
Cognitive function
Cognitive function was assessed immediately prior to the MRI
scan according to a protocol including paper and pencil
instruments based on a systematic review11 and extensively piloted
in patient groups and healthy volunteers: MoCA, Trail Making
Test (TMT A and B), Lexical (letter: ‘F’) and Semantic Fluency
(category: ‘Animals’), Rey–Osterrieth Complex Figure (RCF)
copying, RCF immediate recall, Hopkins Verbal Learning Test
(HVLT-R) immediate recall, Boston Naming Test (BNT), Digit
Span and Digit Coding (from the Wechsler Adult Intelligent
Scale-IV), Test of Premorbid Function (TOPF), HVLT-R delayed
recall and RCF delayed recall (see online supplement for detailed
explanation and references). The test battery was administered by
trained psychology graduates and psychiatrists.
Statistical analysis
MoCA scores were modelled by logistic regression, as implemented
in SPSS 22 for Windows (IBM Corporation, Armonk, New York,
USA). After dichotomising variables at the mean (except for 0–3
MRI scales, where the binary cut-off was between 1 and 2, and
for the MoCA, where we used the conventional screening cut-off
of 25/26), we entered general atrophy, hippocampal atrophy (only
if bilateral), deep white matter changes and periventricular white
matter changes separately as independent variables. The resulting
odds ratios were compared with odds ratios corrected for age,
gender, socioeconomic status, education (years of full-time+half
years of part-time education, as required for correction of TOPF)
and premorbid IQ estimated from TOPF score alone.
Results
The mean age of the 208 participants was 69.2 years (s.d. = 5.4),
and they were predominantly men 169/208 (81.3%). The imaged
sample was representative of the Phase 11 Whitehall cohort for
age, body mass index (BMI) and heart rate, had marginally
shorter education (95% confidence intervals (CIs) for difference
between means: 70.98 to 70.02 years) and lower CES-D scores
(95% CI72.35 to 70.25; see Table DS1 in the online supplement
to this paper). Their mean blood pressure was slightly higher
(systolic: 95% CI 12.9 to 17.5mmHg; diastolic: 95% CI 5.8 to
8.6mmHg). They used more alcohol (95% CI 4.8 to 9.2 units
per week). The ratio of men to women was higher in the imaging
sample (w2 = 13.78; P= 0.0002), and there was an excess of
executive and a relatively smaller proportion of clerical civil
servants (w2 = 14.51; P= 0.0007; d.f. = 2).
In general, participants had relatively good cognitive function.
Using the conventional cut-offs, 11/208 (5.3%) had an abnormal
(519) score on the HVLT-R; 46/208 (22.1%) scored 526 on
the MoCA. The respective normal distribution values, often used
as cut-off for normality (i.e. 1 and 1.5 s.d. below the mean) were
24.6 and 23.4 for the MoCA, and 21.7 and 19.2 for the HVLT-R
(for details of cognitive tests and the psychiatric diagnoses
recorded after Structured Clinical Interview for DSM-IV-TR Axis
I Disorders (SCID-1) interview,12 see online supplement). Inter-
and intrarater reliability for MRI scores was high (ICC 0.8–0.9
and 0.7–0.9 respectively). Scores were approximately normally
distributed (Fig. 1), i.e. the majority of participants had higher
than minimum (perfect) atrophy and white matter scores.
Participants with high (526) and low (526) MoCA scores
were compared for sociodemographic, clinical and cognitive
variables (Table 1). Individuals with low MoCA were slightly older
(F(1,206) = 10.6, P= 0.001), there was an over-representation of
low MoCA in professional (2nd) and clerical (3rd), as opposed
to executive (1st) socioeconomic strata (w2 = 4.5, P= 0.03,
d.f. = 2), but there were no differences in gender (w2 = 0.07,
P= 0.79, d.f. = 1), reported minor neurological history (Guillain-
Barre Syndrome; brain cyst; transient ischaemic attack; migraine;
epilepsy; multiple sclerosis; Parkinsonism; myalgic encephalopathy;
blackout; familial tremor; sleep disorder; w2 = 1.63, P= 0.20,
d.f. = 1), history of major depressive episode (from SCID-1;
w2 = 0.002, P= 0.97, d.f. = 1) or caseness on CES-D (CES-D515;
w2 = 1.04, P= 0.31, d.f. = 1). There were also no differences in
socioeconomic and clinical variables, including alcohol use (Table
1), nor was there a difference in premorbid IQ (F(1,206) = 3.3,
P= 0.07).
Hippocampal atrophy and deep white matter changes (as
defined above) were associated with abnormal MoCA scores.
Although the mean odds ratio for both general atrophy and
periventricular white matter changes were above 1, confidence
intervals indicated no significant effect (Table 2). After correction
for potential confounders (age, gender, socioeconomic status,
years of education and premorbid IQ), only hippocampal atrophy
remained associated with abnormal MoCA. In the presence of
hippocampal atrophy, higher premorbid IQ and social class
(executive rather than professional or clerical) were independently
associated with resilience to cognitive impairment.
Discussion
We observed a significant number of minor MRI abnormalities, in
particular whole brain and hippocampal atrophy, as well as white
matter changes (Fig. 1). Direct comparison with other published
studies is difficult, given the differing imaging protocols, rating
scales and rater expertise. Nonetheless, the Rotterdam scan study,
for example, reported a slightly lower prevalence of white matter
lesions compared with our findings (92% v. 98.5% deep white
matter changes, 80% v. 100% periventricular white matter
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changes).6 Similarly, hippocampal atrophy in older populations
has been reported at lower rates than the 70% we found (e.g.
33%).13 This could reflect a true increased burden of pathological
changes or increased detection by our higher resolution MRI
protocol (all the above studies used a field strength of 1.5T in
contrast to 3T in this project).
Compared with previous studies, the proportion of parti-
cipants with global cognitive impairment was high (20%).14
Potential health concerns may have induced some participants to
attend the testing, so the potential for selection bias cannot be
dismissed, as those concerned about memory problems may have
been more likely to attend. No participant had an established
diagnosis of dementia, which is unsurprising given the study
inclusion criteria (community resident and ability to travel to
Oxford). Unlike the original MoCA validation study,15 our sample
was not a healthy control group but a community sample, which
437
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Fig. 1 Distribution (histograms) of global atrophy, Scheltens and Fazekas scores.
Table 1 Descriptive variables for high (526) and low (526) MoCA groups
Low MoCA group (526) High MoCA group (526)
Variable Mean s.d. n Mean s.d. n
Age, years 71.3 6.1 46 68.5 5.0 162
Alcohol units/week 15.9 15.4 45 16.7 15.8 155
Body-mass index, kg/m2 26.3 4.2 46 26.5 4.4 162
Systolic blood pressure, mmHg 145.7 18.3 46 141.8 17.5 161
Diastolic blood pressure, mmHg 77.3 8.9 45 78.5 10.3 161
Heart rate, beats per minute 66.6 11.7 43 67.9 13.3 161
CES-D score 7.5 7.6 46 5.57 6.8 162
Years of education 16.5 4.3 46 15.5 3.3 162
Premorbid IQa 115.6 12.6 46 118.6 8.9 162
MoCA (correct out of 30) 23 2.0 46 28 1.3 162
Boston naming test (correct out of 60) 54.5 8.6 46 57.8 3.2 162
Digit coding (correct out of 135) 49.3 13.3 46 64.9 12.7 162
Digits backward (correct out of 16) 8.63 2.59 46 10.25 2.57 162
Digits forward (correct out of 16) 10.04 2.17 46 11.16 2.26 162
Digits sequence (correct out of 16) 8.50 2.92 46 10.70 2.49 162
Lexical fluency, words per minute 12.63 5.11 46 16.17 4.31 162
Semantic fluency, words per minute 17.91 5.70 46 22.83 5.63 162
Trail Making Test A, seconds 40.04 17.79 46 29.77 10.97 160
Trail Making Test B, seconds 98.98 49.99 45 58.79 22.85 160
HVLT (delayed recall, correct out of 12) 7.09 3.55 46 9.33 2.71 162
HVLT (immediate recall, correct out of 36) 23.74 5.79 46 27.65 4.48 162
RCFT (copy, correct out of 36) 27.20 6.44 46 30.83 3.78 161
RCFT (delayed recall, correct out of 36) 10.04 5.60 46 15.43 5.99 161
RCFT (immediate recall, correct out of 36) 11.03 6.62 46 15.88 6.07 161
MoCA, Montreal Cognitive Assessment; CES-D, Centre for Epidemiologic Studies – Depression; HVLT, Hopkins Verbal Learning Test; RCFT, Rey–Osterrieth Complex Figure Test.
Results with P50.05 are in bold.
a. Test of premorbid function (IQ corrected for gender and education).
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included those with a history of major (17% of sample) and minor
(9% of sample) depression or bipolar disorder (1% of sample, see
online supplement). Deficits in executive function and attention
are known to persist in euthymic patients with a history of
unipolar depression16 or bipolar disorder,17 although there was
neither an excess of major depressive disorders nor of current
CES-D caseness in the low MoCA group (Table 1). The level of
alcohol use in our cohort (mean 16.5 units/week) may also be
relevant. Frequent or heavy (415 units per week) drinkers may
be at increased risk of cognitive impairment18 and dementia,19
as well as increased ventricle and sulcal size,20 although there
was no difference in alcohol use between high and low MoCA
scorers (Table 1).
Our sample was representative of the larger Whitehall II
cohort for age, BMI and heart rate, but had a marginally shorter
length of full-time education. Although they scored a couple of
points lower on the CES-D depression scale, they used 5–10 units
of alcohol more than the Phase 11 cohort and had a higher blood
pressure. There was an excess of men and of executive civil
servants relative to clerical staff. One implication of these
differences may be that the imaging cohort was more likely to
generate associations relying on variability for cardiovascular risk
factors.
Of the clinical MRI measures, only deep white matter changes
and hippocampal atrophy were significantly associated with
cognitive impairment. After correcting for possible confounder
variables, only hippocampal atrophy remained associated with
MoCA (Table 2). This supports the notion that MoCA may
predict pathological deterioration in memory, rather than
representing the normal process in ageing.21–25 In contrast, global
atrophy and periventricular white matter changes appear to have
little impact on cognition, which lends credence to their being
reported as ‘normal for age’.26 Although a quantitative review
found that white matter changes are associated with poorer global
cognitive function, speed of processing, immediate-recent
memory, delayed memory and executive function,27 not all studies
have corroborated these findings.28 Our finding that deep white
matter changes are associated with MoCA, but that this association
is lost after correcting for potential confounders, may be due to
limited power of a study of even 200 participants.
With a given degree of hippocampal atrophy, higher premorbid
IQ and socioeconomic status (based on civil service grade) but
not education were independently associated with resilience to
cognitive impairment. This lends strength to the cognitive
reserve29 or compensation hypotheses.30 It may also explain why
the Whitehall cohort is resilient to functional deterioration
(several of the mean test scores are higher than published results
at similar ages14,31,32 despite more prevalent structural brain
changes). This cohort has a higher education level33 and a lower
cardiovascular risk profile than those in other studies.34 Finally,
there are a number of other determinants of cognitive reserve not
explored in this study, such as participation in leisure activities,35
cohesion of social networks,36 occupational complexity37 and
personality characteristics that may be responsible for additional
variability.38
We were able to combine 3T MRI imaging with comprehensive
cognitive testing in a large study drawn from an occupational
cohort. Limitations to our study include its cross-sectional design,
and further work needs to include longitudinal and diagnostic
follow-up data. Although previous work has demonstrated the
clinical value of the MRI scales used,39 and our interrater reliability
figures were higher than those quoted in several other studies,40 it
will be valuable to compare our results with automated volumetric
measurements to establish whether the key findings (e.g. that
hippocampal atrophy is highly functionally relevant and premorbid
intelligence and social class confer resilience to functional but not
structural deterioration) can be corroborated. In the meantime,
our results should contribute to the interpretation of ‘age-related’
MRI abnormalities as they are usually reported in clinical practice.
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Table 2 Odds ratios for MoCA (526/526) with normal/abnormal MRI measures
Measure Odds ratios 95% CI P
Uncorrected odds ratio
51 normal hippocampi/both hippocampi abnormal 3.43 1.61–7.31 0.001
No general atrophy/general atrophy 1.83 0.92–3.64 0.09
Normal Fazekas/deep white matter changes 2.28 1.16–4.48 0.02
Normal Fazekas/periventricular white matter changes 1.80 0.92–3.53 0.09
Corrected odds ratiosa
51 normal hippocampi/both hippocampi abnormal 2.75 1.16–6.50 0.02
Age (higher/lower) 0.63 0.29–1.37 0.24
Premorbid IQb (higher/lower) 2.19 1.02–4.71 0.045
Gender (female/male) 1.67 0.60–4.64 0.24
Social class (lower/higher) 0.46 0.22–0.99 0.048
Years of education (higher/lower) 0.50 0.22–1.13 0.095
Results with P50.05 are in bold.
a. Logistic regression with potential predictor and confounder variables: =1 normal hippocampi, age, gender, social class, years of education and premorbid IQ based on Test of
Premorbid Function; n=205.
b. Premorbid IQ calculated from Test of Premorbid Function scores without correction for gender and years of education.
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